Abstract
Since the introduction of simultaneous positron emission tomography magnetic resonance imaging (PET/MR) in 2010, technological advances led to improved image quality, improved attenuation correction, and reduced scan time, leading to an increasing number of clinical applications for this new technology. Lower radiation exposure and higher soft-tissue contrast are the main advantages of PET/MR over PET/CT. However, its real added value in clinical applications is still under investigation. This short review is focusing on three PET/MR applications that had an increasing clinical acceptance in our institution and where we believe that PET/MR will play an important role in the future: prostate cancer, head and neck cancer, and cardiac imaging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IEEE Transactions on Radiation and Plasma Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
